☆ 4.6 Article

Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study

CANCER MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study

Mostafa H. Abd El Wahab et al.

Summary: Since the declaration of the SARS-CoV-2 pandemic, the healthcare systems worldwide have been heavily burdened, and cancer patients are particularly affected. This study examines the impact of COVID-19 on the presentation of breast cancer, focusing on TNM staging, and finds an increase in late-stage breast cancer cases in the post-pandemic period.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2023)

Add to Collection

Article Oncology

Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada

Agnihotram Ramanakumar et al.

Summary: This study investigates the impact of the COVID-19 pandemic on cancer diagnoses in the province of Quebec, Canada. The findings suggest that cancer diagnosis was underestimated in the first year of the pandemic, with a greater impact observed in the initial phase of the outbreak.

CANCER MEDICINE (2023)

Add to Collection

Article Oncology

Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race

Jennifer Berrian et al.

Summary: The COVID-19 pandemic did not significantly exacerbate racial disparities in late-stage presentation of breast, colorectal, lung, and prostate cancers.

CANCER MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Estimation of Oncologic Surgery Case Volume Before and After the COVID-19 Pandemic in France

Christine Le Bihan-Benjamin et al.

Summary: This study aims to examine approaches that may better assess the use of cancer surgeries. The findings suggest that short- and medium-term trends must be considered to estimate COVID-19 cancer surgery activities. Breast cancer showed the smallest decrease during the pandemic, with almost full recovery in 2021.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Medicine, General & Internal

Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic

Christopher Doan et al.

Summary: Several studies have shown that breast cancer screening and low-dose computed tomographic screening for lung cancer decreased sharply during the early months of the COVID-19 pandemic, but returned to normal or near-normal levels in the summer of 2020. This retrospective cohort study aimed to determine the observed vs expected rates of mammography and low-dose computed tomographic scans from the beginning of the pandemic through April 2022. The findings indicate that despite improvements in the pandemic situation, the screening rates remained below expected levels.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Oncology

Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity

Ilana Richman et al.

Summary: The COVID-19 pandemic has severely disrupted routine healthcare in the United States, including the complete halt of screening mammography and the emergence of disparities in screening rates across different populations. These disparities can be attributed to various structural and contextual factors, with strategies to close the gaps requiring a multifaceted approach that addresses both healthcare systems/practices and policy-level measures. Addressing health disparities necessitates comprehensive solutions that tackle the complex conditions leading to disparities.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Article Oncology

Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021)

Gregorio Garrido-Cantero et al.

Summary: The COVID-19 pandemic has significantly disrupted cancer diagnosis, treatment and prevention, with certain cancers remaining severely impacted. Strategies are needed to recover the backlog of diagnoses and effectively treat these cases in the future.

CANCERS (2023)

Add to Collection

Review Oncology

A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

Tong Li et al.

Summary: This systematic review examines the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. The findings show a significant reduction in screening volumes and the number of diagnosed breast cancers during the pandemic, as well as an increase in the proportion of advanced stage cancer at diagnosis.

BREAST (2023)

Add to Collection

Article Oncology

The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England

Toral Gathani et al.

Summary: Cancer services were significantly disrupted during the COVID-19 pandemic, resulting in a substantial decrease in breast cancer diagnoses. However, these diagnoses have now recovered to at least pre-pandemic levels. Long-term follow-up is necessary to evaluate the impact on outcomes.

BRITISH JOURNAL OF CANCER (2023)

Add to Collection

Article Oncology

Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic

Kayo Adachi et al.

Summary: We analysed the impact of the COVID-19 pandemic on breast cancer mortality in Japan and found that the suspension of breast cancer screening services led to increased aggression and advanced stages of the disease. This may have a negative impact on the long-term clinical outcomes of breast cancer patients.

CLINICAL BREAST CANCER (2023)

Add to Collection

Article Oncology

Impact of COVID-19 on Breast Cancer Management in a Multiethnic Middle-Income Asian Country Setting

Ng Jing Hui et al.

Summary: This study assessed the impact of the COVID-19 pandemic on breast cancer demography, clinicopathological characteristics, and patient management at a teaching hospital in Kuala Lumpur, Malaysia. The study found that COVID-19 caused operational changes in breast cancer management, including a reduction in reconstructive procedures and adjuvant treatment. There was a decrease in screening-detected carcinoma, mastectomy followed by immediate reconstruction, and adjuvant chemotherapy during the COVID-19 period.

EUROPEAN JOURNAL OF BREAST HEALTH (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, France

Clemence Feron Agbo et al.

Summary: Due to the priority given to COVID-19 patients, the management of patients with chronic diseases, including cancer, was compromised. This study examined the impact of COVID-19 on the stage of discovery and treatment time for breast cancer patients in a screening program. The results showed no significant difference in the stage of breast cancer at discovery or in treatment time, but there was an increase in the number of invasive cancers and the size of in situ cancers in 2020. Continued monitoring is needed to assess the long-term effects of the pandemic.

PREVENTIVE MEDICINE REPORTS (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre

Pierre-Antoine Linck et al.

Summary: The COVID-19 lockdown led to a 20% decrease in diagnosed breast cancer cases, but there was a 48% increase after the lockdown. Breast cancers diagnosed after the lockdown were more symptomatic, had larger tumors, and higher rates of lymph node invasion compared to the reference period.

EUROPEAN RADIOLOGY (2022)

Add to Collection

Article Oncology

Pattern of breast cancer presentation during the coronavirus disease pandemic: results from a cohort study in the UK

Kim Borsky et al.

Summary: This study examines whether delays in presentation during the COVID-19 pandemic have led to patients with more advanced breast cancers in 2020 compared to 2019. The results show that patients in 2020 presented with higher UICC stages, more node-positive cases, and more metastatic disease on initial diagnosis compared to 2019.

FUTURE ONCOLOGY (2022)

Add to Collection

Article Oncology

Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals

Emmanuelle Kempf et al.

Summary: This study aimed to assess the indicators of new colorectal cancer patients before and after the beginning of the pandemic in France. The results showed that the SARS-Cov2 pandemic was associated with a decrease in newly diagnosed CRC patients and worse 1-year survival rates, primarily attributed to the infection itself.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Surgery

Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment

Ashley Cairns et al.

Summary: The COVID-19 pandemic had a greater impact on mammography rates than on breast cancer surgery cases. There was a significant decline in screening and diagnostic mammograms, while the number of new breast cancer operations remained relatively stable. Further data collection is needed to assess the long-term effects on morbidity, mortality, and disparities in breast cancer care caused by delays due to COVID-19.

AMERICAN SURGEON (2022)

Add to Collection

Review Public, Environmental & Occupational Health

Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis

Jay Shen Ng et al.

Summary: The COVID-19 pandemic has had a substantial impact on breast cancer screening and diagnosis rates, with greater reductions observed in countries under lockdown restrictions.

JOURNAL OF MEDICAL SCREENING (2022)

Add to Collection

Article Surgery

Breast reconstruction during the COVID-19 pandemic: Single institution experience from the pandemic's epicenter in the United States

Carter J. Boyd et al.

Summary: This study aimed to quantify the impact of the COVID-19 pandemic on breast cancer screening, treatment, and reconstruction at a medical institution in New York City. The results showed a decline in mammography, oncologic breast surgeries, and breast reconstruction in 2020, but a rebound in 2021. Changes in the types of reconstruction were also noted.

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2022)

Add to Collection

Article Oncology

Effects of COVID-19 on mastectomy and breast reconstruction rates: A national surgical sample

Robyn N. Rubenstein et al.

Summary: The COVID-19 pandemic had significant effects on breast cancer surgeries and reconstruction rates. There was a decrease in overall surgery volume, but mastectomy and reconstruction rates remained stable. The use of outpatient alloplastic reconstruction increased, and the length of hospital stay decreased for all reconstruction types.

JOURNAL OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Monitoring the impact of COVID-19 in France on cancer care: a differentiated impact

Christine Le Bihan Benjamin et al.

Summary: The COVID-19 pandemic has had a substantial impact on cancer care, with a significant decline in activities during the first lockdown. While there has been some recovery in the following months, the shortfall from the initial lockdown was not fully compensated for.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic

Shengdong He et al.

Summary: The outbreak of COVID-19 has led to delayed treatment for breast cancer patients. Factors such as higher education levels, poor self-feeling, low medical order compliance, higher levels of anxiety and depression, and traffic inconvenience contribute to this delay.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Surgery

Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19

Kathryn Isaac et al.

Summary: This study aims to develop best practice recommendations for breast reconstructive services during the COVID-19 pandemic. By strategically using resources, shared decision-making, and targeted application of management strategies, optimal provision of breast reconstructive services can be achieved.

PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2022)

Add to Collection

Article Oncology

Impact of COVID-19 pandemic on breast cancer care: report from a regional cancer centre

Budhi Yadav et al.

LANCET ONCOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database

Lars J. Grimm et al.

Journal of the American College of Radiology (2022)

Add to Collection

Article Biology

Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study

Guillermo Bosch et al.

Summary: The COVID-19 pandemic had a negative impact on breast cancer screening, leading to lower participation rates and decreased recall and false positives. However, there were no significant differences in cancer detection rate or cancer stages.

ELIFE (2022)

Add to Collection

Article Oncology

Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil

Cristiano A. A. Resende et al.

Summary: This study evaluated the impact of the COVID-19 pandemic on breast cancer diagnosis in Brazil. The results showed a decrease in early-stage breast cancer and an increase in advanced-stage breast cancer during the pandemic. Older age and postmenopausal status were associated with a higher risk of advanced-stage breast cancer during the pandemic period.

JCO GLOBAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

Giulia Mentrasti et al.

Summary: The COVID-19 pandemic has had an impact on the diagnosis and treatment of breast cancer patients in 2020, resulting in a significant reduction in early stage breast cancer cases. Despite the upheaval caused by the pandemic, Italian Oncology Departments have delivered effective healthcare services.

BREAST (2022)

Add to Collection

Article Oncology

Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience

Agnese Losurdo et al.

Summary: This study evaluates the performance of Italian Breast Centers during the COVID-19 pandemic compared to pre-pandemic times, and finds that there were no delays or changes in BC treatment in the Senonetwork partners, contradicting the globally reported decrease in performance of Italian Breast Centers.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Add to Collection

Article Oncology

Impact of the COVID-19 pandemic on breast cancer management: Experience of a French Comprehensive Cancer Center

Melanie Tran et al.

Summary: The study reveals a decrease in breast cancer activities during the first lockdown of 2020, followed by a recovery in early 2021. There were no significant differences found in treatment sequences, cancer stages, age at diagnosis, or place of residence between 2019 and 2020-2021.

BULLETIN DU CANCER (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Was there any delay in the treatment of breast cancer patients because of the COVID-19 stringency measures?

F Estupiñán-Romero et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2022)

Add to Collection

Article Oncology

The Impact of the COVID-19 Pandemic on Breast Cancer Patients

Ahmet Serkan Ilgun et al.

Summary: This study investigated the effects of the COVID-19 pandemic on breast cancer patients treated at our breast center. The results showed a decrease in the number of patients seeking treatment and an increase in patient-related delay time during the pandemic, along with a significant increase in de novo stage IV breast cancer.

EUROPEAN JOURNAL OF BREAST HEALTH (2022)

Add to Collection

Article Oncology

What Has Changed During the COVID-19 Pandemic?-The Effect on an Academic Breast Department in Portugal

Diana Simao et al.

Summary: The study found that there was a 40% reduction in the number of breast cancer patients in Portugal during the lockdown. However, there was a significant increase in the proportion of metastatic breast cancer patients receiving systemic therapy for the first time, as well as an increase in the number of patients with bilateral early breast cancer at diagnosis. These findings suggest the need for accelerated restoration of breast cancer screening to reduce the incidence of advanced cases and mitigate the impact of the COVID-19 pandemic on cancer patients.

EUROPEAN JOURNAL OF BREAST HEALTH (2022)

Add to Collection

Review Oncology

Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic

Kathryn Hawrot et al.

Summary: The study retrospectively analyzed the impact of COVID-19 on newly diagnosed breast cancer patients in 2020, finding a decrease in patient volume, no delays in treatment initiation, and a shift in initial treatment modality.

JCO ONCOLOGY PRACTICE (2021)

Add to Collection

Article Oncology

New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown

Emmanuelle Kempf et al.

Summary: The spread of SARS-Cov2 led to a substantial decrease in new cancer cases, affecting patients of different age groups and cancer types. This trend may impact clinical outcomes in the coming years.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic

Gianluca Vanni et al.

Summary: The COVID-19 lockdown measures had a significant impact on breast cancer patients, leading to increased tumor dimensions, advanced N-staging, and increased need for adjuvant treatments.

ANTICANCER RESEARCH (2021)

Add to Collection

Article Oncology

The Impact of the COVID-19 Pandemic on Breast Reconstruction Practices in the United States

Walter J. Joseph et al.

Summary: A survey conducted by the American Society of Plastic Surgeons (ASPS) during the COVID-19 pandemic found that most respondents continued with breast reconstruction as originally planned, with tissue expander/implant-based reconstruction being the most common choice. Most institutions implemented restrictions, and almost all respondents reported mandatory pre-operative SARS-Cov-2 testing once cases resumed.

ANTICANCER RESEARCH (2021)

Add to Collection

Article Oncology

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling

Oguzhan Alagoz et al.

Summary: The study projected the long-term impact of initial disruptions in breast cancer care due to COVID-19, estimating a small increase in breast cancer mortality by 2030. However, efforts to promptly return to screening and minimize delays in treatment evaluation can largely mitigate this impact.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Review Oncology

Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies

Luc Ceugnart et al.

BULLETIN DU CANCER (2020)

Add to Collection

Article Oncology

COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the College Nationale des Gynecologues et Obstetriciens Francais (CNGOF), the Societe d'Imagerie de la Femme (SIFEM), the Societe Francaise de Chirurgie Oncologique (SFCO), the Societe Francaise de Senologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)

Joseph Gligorov et al.

BULLETIN DU CANCER (2020)

Add to Collection

Article Oncology

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

Elizabeth Lerner Papautsky et al.

BREAST CANCER RESEARCH AND TREATMENT (2020)

Add to Collection

Article Oncology

The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit

A. Fancellu et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis

Shibin Cai et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Oncology

Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients

Gianluca Vanni et al.

ANTICANCER RESEARCH (2020)

Add to Collection

Article Oncology

The y symbol: An important classification tool for neoadjuvant cancer treatment

JD Brierley et al.

CANCER (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.